These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35116906)

  • 1. A case report of small bowel adenocarcinoma with liver metastases: genetic profiling and clinical management.
    Ali WAS; Liu W; Xiao Y; Fang J; Xu Q
    Transl Cancer Res; 2019 Aug; 8(4):1624-1629. PubMed ID: 35116906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.
    Zheng Z; Zhou X; Zhang J; Zhao B; Chen C; Liu X; Cao H; Li T; Geng R; Wang W; Li Y
    Int J Clin Oncol; 2021 Feb; 26(2):387-398. PubMed ID: 33113018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational study.
    Elriz K; Carrat F; Carbonnel F; Marthey L; Bouvier AM; Beaugerie L;
    Inflamm Bowel Dis; 2013 Aug; 19(9):1823-6. PubMed ID: 23702807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
    Takayoshi K; Kusaba H; Uenomachi M; Mitsugi K; Makiyama C; Makiyama A; Uchino K; Shirakawa T; Shibata Y; Shinohara Y; Inadomi K; Tsuchihashi K; Arita S; Ariyama H; Esaki T; Akashi K; Baba E
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):333-342. PubMed ID: 28653251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.
    Zaaimi Y; Aparicio T; Laurent-Puig P; Taieb J; Zaanan A
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):154-60. PubMed ID: 26547136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peritoneal metastases from small bowel adenocarcinoma.
    Rovers KP; de Bree E; Yonemura Y; de Hingh IH
    Int J Hyperthermia; 2017 Aug; 33(5):571-578. PubMed ID: 27919181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
    Gulhati P; Raghav K; Shroff RT; Varadhachary GR; Kopetz S; Javle M; Qiao W; Wang H; Morris J; Wolff RA; Overman MJ
    Cancer; 2017 May; 123(6):1011-1017. PubMed ID: 27859010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.
    Overman MJ; Adam L; Raghav K; Wang J; Kee B; Fogelman D; Eng C; Vilar E; Shroff R; Dasari A; Wolff R; Morris J; Karunasena E; Pisanic TR; Azad N; Kopetz S
    Ann Oncol; 2018 Jan; 29(1):139-144. PubMed ID: 29069279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management.
    Gelsomino F; Balsano R; De Lorenzo S; Garajová I
    Curr Oncol; 2022 Feb; 29(2):1223-1236. PubMed ID: 35200603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
    Legué LM; van Erning FN; Bernards N; Lemmens VEPP; de Hingh IHJT; Creemers GJ
    Target Oncol; 2019 Dec; 14(6):699-705. PubMed ID: 31625001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving management of small bowel adenocarcinoma.
    de Bree E; Rovers KP; Stamatiou D; Souglakos J; Michelakis D; de Hingh IH
    Acta Oncol; 2018 Jun; 57(6):712-722. PubMed ID: 29381126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
    Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
    Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater.
    Gulhati P; Raghav K; Shroff R; Varadhachary G; Javle M; Qiao W; Wang H; Morris J; Wolff R; Overman MJ
    Oncologist; 2018 Mar; 23(3):277-e26. PubMed ID: 29259073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
    Trikudanathan G; Dasanu CA
    Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience.
    Khan K; Peckitt C; Sclafani F; Watkins D; Rao S; Starling N; Jain V; Trivedi S; Stanway S; Cunningham D; Chau I
    BMC Cancer; 2015 Jan; 15():15. PubMed ID: 25603878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum.
    Hirao M; Komori M; Nishida T; Iijima H; Yamaguchi S; Ishihara R; Yasunaga Y; Kobayashi I; Kishida O; Oshita M; Hagiwara H; Ito T; Suzuki K; Hayashi Y; Inoue T; Tsujii M; Yoshihara H; Takehara T
    Oncol Lett; 2017 Aug; 14(2):1628-1636. PubMed ID: 28789389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of small bowel adenocarcinoma liver metastasis combined with neoadjuvant and adjuvant chemotherapy results in extended disease-free period--a case report.
    Eigenbrod T; Kullmann F; Klebl F
    Int J Gastrointest Cancer; 2006; 37(2-3):94-7. PubMed ID: 17827529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of small bowel adenocarcinoma in Crohn's disease compares favourably with de novo small bowel adenocarcinoma.
    Wieghard N; Mongoue-Tchokote S; Young JI; Sheppard BC; Tsikitis VL
    Colorectal Dis; 2017 May; 19(5):446-455. PubMed ID: 27659145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and treatment outcomes of metastatic or locally unresectable small bowel adenocarcinoma.
    Li X; Ying H; Cheng Y; Zhao L; Zhao S; Bai C; Zhou J
    J BUON; 2019; 24(6):2539-2545. PubMed ID: 31983130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Landscape of Small Bowel Adenocarcinoma.
    Pandya K; Overman MJ; Gulhati P
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.